HWM
ADMA icon

Hemington Wealth Management’s ADMA Biologics ADMA Stock Holding History

Hemington Wealth Management’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$1K Sell
107
-91
-46% -$1.56K ﹤0.01% 1396
2025
Q2 		$3K Buy
198
+37
+23% +$754 ﹤0.01% 1206
2025
Q1 		$3K Buy
161
+47
+41% +$813 ﹤0.01% 1159
2024
Q4 		$1K Buy
114
+26
+30% +$489 ﹤0.01% 1355
2024
Q3 		$1K Buy
+88
New +$1.37K ﹤0.01% 1267

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.82B AUM 73.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Hemington Wealth Management's ADMA Position: Q3 2025 in Review

Hemington Wealth Management reduced its ADMA Biologics (ADMA) stake by 46% in Q3 2025, selling an estimated $1.56K and leaving 107 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1396.

Hemington Wealth Management first reported a position in ADMA in Q3 2024 and has held it in 5 quarters since. The position peaked at $3K in Q2 2025. 365 funds tracked by Wall St. Rank hold ADMA as of Q3 2025.

  • Hemington Wealth Management held 107 shares of ADMA Biologics worth $1K as of Q3 2025.
  • Hemington Wealth Management sold 91 ADMA Biologics shares in Q3 2025, an estimated $1.56K.
  • ADMA Biologics made up ﹤0.01% of Hemington Wealth Management's portfolio in Q3 2025, its #1396 holding.
  • Hemington Wealth Management first reported a position in ADMA Biologics in Q3 2024 and has held it in 5 quarters since.
  • Hemington Wealth Management's ADMA Biologics position peaked at $3K in Q2 2025.
  • 365 funds tracked by Wall St. Rank held ADMA Biologics as of Q3 2025.

Based on Hemington Wealth Management's 13F filing for Q3 2025, filed 24 Oct 2025.